GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Buyback Yield %

Atomo Diagnostics (ASX:AT1) Buyback Yield % : 1.72 (As of Apr. 12, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Atomo Diagnostics's current buyback yield was 1.72%.


Atomo Diagnostics Buyback Yield % Historical Data

The historical data trend for Atomo Diagnostics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Buyback Yield % Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Buyback Yield %
-14.58 -1.06 -0.21 - -12.83

Atomo Diagnostics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -16.06 -12.83 1.72

Competitive Comparison of Atomo Diagnostics's Buyback Yield %

For the Medical Devices subindustry, Atomo Diagnostics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atomo Diagnostics's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's Buyback Yield % falls into.


;
;

Atomo Diagnostics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Atomo Diagnostics's Buyback Yield for the fiscal year that ended in Jun. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2.05) / 15.98005
=-12.83%

Atomo Diagnostics's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + -0.209) / 12.144838
=1.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Atomo Diagnostics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Atomo Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines